Effect of the combination of mitiglinide and metformin on glycemic control in patients with type 2 diabetes mellitus

Aims/Introduction:  Mitiglinide is the newest drug in the meglitinide family. It increases the early‐phase insulin release through rapid association‐dissociation kinetics in the pancreatic β cells. The efficacy and safety of adding meglitinide to metformin monotherapy in patients with type 2 diabete...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Young Min, Koo, Bo Kyung, Son, Ho Young, Lee, Kwang Woo, Son, Hyun Shik, Choi, Dong Seop, Kim, Bo Wan, Kim, Yong Ki, Lee, Moon Kyu, Lee, Hyun Chul, Min, Kyung Wan, Chung, Min Young, Baek, Hong Sun, Kim, Youngkun, Yoo, Hyung Joon, Park, Kyong Soo, Lee, Hong Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2010
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008006/
https://www.ncbi.nlm.nih.gov/pubmed/24843423
http://dx.doi.org/10.1111/j.2040-1124.2010.00023.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008006/
https://www.ncbi.nlm.nih.gov/pubmed/24843423
http://dx.doi.org/10.1111/j.2040-1124.2010.00023.x

Ejemplares similares